XML 26 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Guarantor Non-Guarantor Subsidiary Financial Information Level 3 (Tables)
6 Months Ended
Jun. 30, 2014
Guarantor - Condensed Consolidating Statements of Operations [Abstract]  
Condensed Consolidating Balance Sheet [Table Text Block]
MOMENTIVE SPECIALTY CHEMICALS INC.
JUNE 30, 2014
CONDENSED CONSOLIDATING BALANCE SHEET (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Assets
 
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents (including restricted cash of $0, $0 and $16, respectively)
$
30

 
$
2

 
$

 
$
103

 
$

 
$
135

Short-term investments

 

 

 
4

 

 
4

Accounts receivable, net
213

 
3

 
2

 
510

 

 
728

Intercompany accounts receivable
115

 
89

 

 
370

 
(574
)
 

Intercompany loans receivable - current portion
211

 

 

 
245

 
(456
)
 

Inventories:
 
 
 
 
 
 
 
 
 
 
 
Finished and in-process goods
124

 

 

 
207

 

 
331

Raw materials and supplies
65

 

 

 
89

 

 
154

Other current assets
23

 

 

 
45

 

 
68

Total current assets
781

 
94

 
2

 
1,573

 
(1,030
)
 
1,420

Investment in unconsolidated entities
359

 

 
32

 
30

 
(372
)
 
49

Deferred income taxes

 

 

 
19

 

 
19

Other assets, net
23

 
58

 
1

 
56

 

 
138

Intercompany loans receivable
1,165

 
3,364

 
30

 
2,517

 
(7,076
)
 

Property and equipment, net
517

 

 

 
565

 

 
1,082

Goodwill
66

 

 

 
60

 

 
126

Other intangible assets, net
59

 

 

 
32

 

 
91

Total assets
$
2,970

 
$
3,516

 
$
65

 
$
4,852

 
$
(8,478
)
 
$
2,925

Liabilities and (Deficit) Equity
 
 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
 
 
Accounts payable
$
160

 
$

 
$

 
$
350

 
$

 
$
510

Intercompany accounts payable
136

 
4

 

 
434

 
(574
)
 

Debt payable within one year
20

 

 

 
117

 

 
137

Intercompany loans payable within one year
56

 

 

 
400

 
(456
)
 

Interest payable
9

 
73

 

 
1

 

 
83

Income taxes payable
4

 

 

 
13

 

 
17

Accrued payroll and incentive compensation
26

 

 

 
36

 

 
62

Other current liabilities
64

 

 

 
55

 

 
119

Total current liabilities
475

 
77

 

 
1,406

 
(1,030
)
 
928

Long-term liabilities:
 
 
 
 
 
 
 
 
 
 
 
Long-term debt
354

 
3,326

 

 
29

 

 
3,709

Intercompany loans payable
3,402

 

 
8

 
3,666

 
(7,076
)
 

Accumulated losses of unconsolidated subsidiaries in excess of investment
699

 

 
266

 

 
(965
)
 

Long-term pension and post employment benefit obligations
43

 

 

 
183

 

 
226

Deferred income taxes
8

 
2

 

 
12

 

 
22

Other long-term liabilities
105

 
6

 

 
46

 

 
157

Total liabilities
5,086

 
3,411

 
274

 
5,342

 
(9,071
)
 
5,042

Total Momentive Specialty Chemicals Inc. shareholders (deficit) equity
(2,116
)
 
105

 
(209
)
 
(489
)
 
593

 
(2,116
)
Noncontrolling interest

 

 

 
(1
)
 

 
(1
)
Total (deficit) equity
(2,116
)
 
105

 
(209
)
 
(490
)
 
593

 
(2,117
)
Total liabilities and (deficit) equity
$
2,970

 
$
3,516

 
$
65

 
$
4,852

 
$
(8,478
)
 
$
2,925

MOMENTIVE SPECIALTY CHEMICALS INC.
DECEMBER 31, 2013
CONDENSED CONSOLIDATING BALANCE SHEET
  
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Assets
 
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents (including restricted cash of $0, $0 and $14, respectively)
$
165

 
$
5

 
$

 
$
223

 
$

 
$
393

Short-term investments

 

 

 
7

 

 
7

Accounts receivable, net
179

 

 

 
422

 

 
601

Intercompany accounts receivable
190

 
89

 

 
374

 
(653
)
 

Intercompany loans receivable - current portion
216

 

 

 
278

 
(494
)
 

Inventories:
 
 
 
 
 
 
 
 
 
 
 
Finished and in-process goods
105

 

 

 
152

 

 
257

Raw materials and supplies
38

 

 

 
65

 

 
103

Other current assets
27

 

 

 
45

 

 
72

Total current assets
920

 
94

 

 
1,566

 
(1,147
)
 
1,433

Investment in unconsolidated entities
351

 

 
29

 
28

 
(363
)
 
45

Deferred income taxes

 

 

 
21

 

 
21

Other assets, net
31

 
59

 
2

 
42

 

 
134

Intercompany loans receivable
1,251

 
3,355

 
29

 
4,221

 
(8,856
)
 

Property and equipment, net
491

 

 

 
556

 

 
1,047

Goodwill
52

 

 

 
60

 

 
112

Other intangible assets, net
47

 

 

 
35

 

 
82

Total assets
$
3,143

 
$
3,508

 
$
60

 
$
6,529

 
$
(10,366
)
 
$
2,874

Liabilities and (Deficit) Equity
 
 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
 
 
Accounts payable
$
165

 
$

 
$

 
$
318

 
$

 
$
483

Intercompany accounts payable
130

 

 

 
523

 
(653
)
 

Debt payable within one year
20

 

 

 
89

 

 
109

Intercompany loans payable within one year
173

 

 

 
321

 
(494
)
 

Interest payable
10

 
72

 

 
1

 

 
83

Income taxes payable
4

 

 

 
8

 

 
12

Accrued payroll and incentive compensation
19

 

 

 
28

 

 
47

Other current liabilities
65

 

 

 
62

 

 
127

Total current liabilities
586

 
72

 

 
1,350

 
(1,147
)
 
861

Long term liabilities:
 
 
 
 
 
 
 
 
 
 
 
Long-term debt
309

 
3,326

 

 
30

 

 
3,665

Intercompany loans payable
3,388

 

 
7

 
5,461

 
(8,856
)
 

Accumulated losses of unconsolidated subsidiaries in excess of investment
762

 

 
261

 

 
(1,023
)
 

Long-term pension and post employment benefit obligations
50

 

 

 
184

 

 
234

Deferred income taxes
7

 
2

 

 
12

 

 
21

Other long-term liabilities
110

 
6

 

 
47

 

 
163

Total liabilities
5,212

 
3,406

 
268

 
7,084

 
(11,026
)
 
4,944

Total Momentive Specialty Chemicals Inc. shareholders (deficit) equity
(2,069
)
 
102

 
(208
)
 
(554
)
 
660

 
(2,069
)
Noncontrolling interest

 

 

 
(1
)
 

 
(1
)
Total (deficit) equity
(2,069
)
 
102

 
(208
)
 
(555
)
 
660

 
(2,070
)
Total liabilities and (deficit) equity
$
3,143

 
$
3,508

 
$
60

 
$
6,529

 
$
(10,366
)
 
$
2,874

Condensed Consolidating Statement of Operations [Table Text Block]
MOMENTIVE SPECIALTY CHEMICALS INC.
THREE MONTHS ENDED JUNE 30, 2014
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$
595

 
$

 
$

 
$
804

 
$
(62
)
 
$
1,337

Cost of sales
524

 

 

 
712

 
(62
)
 
1,174

Gross profit
71

 

 

 
92

 

 
163

Selling, general and administrative expense
27

 

 

 
68

 

 
95

Business realignment costs
10

 

 

 
2

 

 
12

Other operating expense (income), net
2

 

 

 
(3
)
 

 
(1
)
Operating income
32

 

 

 
25

 

 
57

Interest expense, net
7

 
67

 

 
2

 

 
76

Intercompany interest expense (income), net
44

 
(68
)
 

 
24

 

 

Other non-operating expense (income), net
5

 

 

 
(2
)
 

 
3

(Loss) income before income tax and (losses) earnings from unconsolidated entities
(24
)
 
1

 

 
1

 

 
(22
)
Income tax expense

 

 

 
11

 

 
11

(Loss) income before (losses) earnings from unconsolidated entities
(24
)
 
1

 

 
(10
)
 

 
(33
)
(Losses) earnings from unconsolidated entities, net of taxes
(3
)
 

 
5

 
1

 
3

 
6

Net (loss) income
$
(27
)
 
$
1

 
$
5

 
$
(9
)
 
$
3

 
$
(27
)
Comprehensive (loss) income
$
(29
)
 
$

 
$
6

 
$
(16
)
 
$
10

 
$
(29
)
MOMENTIVE SPECIALTY CHEMICALS INC.
THREE MONTHS ENDED JUNE 30, 2013
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$
572

 
$

 
$

 
$
729

 
$
(51
)
 
$
1,250

Cost of sales
485

 

 

 
664

 
(51
)
 
1,098

Gross profit
87

 

 

 
65

 

 
152

Selling, general and administrative expense
29

 

 

 
60

 

 
89

Asset impairments

 

 

 
7

 

 
7

Business realignment costs
2

 

 

 

 

 
2

Other operating (income) expense, net
(1
)
 

 

 
6

 

 
5

Operating income (loss)
57

 

 

 
(8
)
 

 
49

Interest expense, net
8

 
67

 

 
1

 

 
76

Intercompany interest expense (income), net
47

 
(67
)
 

 
20

 

 

Other non-operating (income) expense, net
(8
)
 

 

 
6

 

 
(2
)
Income (loss) before income tax and (losses) earnings from unconsolidated entities
10

 

 

 
(35
)
 

 
(25
)
Income tax (benefit) expense
(4
)
 

 

 
10

 

 
6

Income (loss) before (losses) earnings from unconsolidated entities
14

 

 

 
(45
)
 

 
(31
)
(Losses) earnings from unconsolidated entities, net of taxes
(42
)
 

 
(17
)
 
1

 
61

 
3

Net loss
$
(28
)
 
$

 
$
(17
)
 
$
(44
)
 
$
61

 
$
(28
)
Comprehensive (loss) income
$
(43
)
 
$
1

 
$
(16
)
 
$
(62
)
 
$
77

 
$
(43
)


MOMENTIVE SPECIALTY CHEMICALS INC.
SIX MONTHS ENDED JUNE 30, 2014
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS (Unaudited)

 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$
1,173

 
$

 
$

 
$
1,576

 
$
(119
)
 
$
2,630

Cost of sales
1,029

 

 

 
1,393

 
(119
)
 
2,303

Gross profit
144

 

 

 
183

 

 
327

Selling, general and administrative expense
55

 

 

 
136

 

 
191

Business realignment costs
15

 

 

 
3

 

 
18

Other operating expense, net
3

 

 

 

 

 
3

Operating income
71

 

 

 
44

 

 
115

Interest expense, net
15

 
134

 

 
4

 

 
153

Intercompany interest expense (income), net
87

 
(136
)
 

 
49

 

 

Other non-operating expense, net
5

 

 

 

 

 
5

(Loss) income before income tax and (losses) earnings from unconsolidated entities
(36
)
 
2

 

 
(9
)
 

 
(43
)
Income tax (benefit) expense
(1
)
 

 

 
22

 

 
21

(Loss) income before (losses) earnings from unconsolidated entities
(35
)
 
2

 

 
(31
)
 

 
(64
)
(Losses) earnings from unconsolidated entities, net of taxes
(19
)
 

 
4

 
2

 
23

 
10

Net (loss) income
$
(54
)
 
$
2

 
$
4

 
$
(29
)
 
$
23

 
$
(54
)
Comprehensive (loss) income
$
(50
)
 
$
1

 
$
5

 
$
(25
)
 
$
19

 
$
(50
)

MOMENTIVE SPECIALTY CHEMICALS INC.
SIX MONTHS ENDED JUNE 30, 2013
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS (Unaudited)
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$
1,109

 
$

 
$

 
$
1,437

 
$
(104
)
 
$
2,442

Cost of sales
949

 

 

 
1,302

 
(104
)
 
2,147

Gross profit
160

 

 

 
135

 

 
295

Selling, general and administrative expense
57

 

 

 
124

 

 
181

Asset impairments

 

 

 
7

 

 
7

Business realignment costs
6

 

 

 
5

 

 
11

Other operating expense (income), net
3

 
(4
)
 

 
3

 

 
2

Operating income (loss)
94

 
4

 

 
(4
)
 

 
94

Interest expense, net
18

 
128

 

 
4

 

 
150

Intercompany interest expense (income), net
91

 
(130
)
 

 
39

 

 

Loss on extinguishment of debt
2

 

 

 
4

 

 
6

Other non-operating expense (income), net
7

 

 

 
(4
)
 

 
3

(Loss) income before income tax and (losses) earnings from unconsolidated entities
(24
)
 
6

 

 
(47
)
 

 
(65
)
Income tax (benefit) expense
(42
)
 
1

 

 
15

 

 
(26
)
Income (loss) before (losses) earnings from unconsolidated entities
18

 
5

 

 
(62
)
 

 
(39
)
(Losses) earnings from unconsolidated entities, net of taxes
(50
)
 

 
(23
)
 
2

 
78

 
7

Net (loss) income
$
(32
)
 
$
5

 
$
(23
)
 
$
(60
)
 
$
78

 
$
(32
)
Comprehensive (loss) income
$
(60
)
 
$
5

 
$
(23
)
 
$
(78
)
 
$
96

 
$
(60
)
Condensed Consolidating Statement of Cash Flows [Table Text Block]
MOMENTIVE SPECIALTY CHEMICALS INC.
SIX MONTHS ENDED JUNE 30, 2013
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Cash flows provided by (used in) operating activities
$
7

 
$
1

 
$
13

 
$
9

 
$
(95
)
 
$
(65
)
Cash flows provided by (used in) investing activities
 
 
 
 
 
 
 
 
 
 
 
Capital expenditures
(29
)
 

 

 
(31
)
 

 
(60
)
Capitalized interest

 

 

 
(1
)
 

 
(1
)
Purchases of debt securities, net

 

 

 
(1
)
 

 
(1
)
Capital contribution to subsidiary
(15
)
 

 
(10
)
 

 
25

 

Change in restricted cash

 

 

 
15

 

 
15

Proceeds from sale of assets

 

 

 
1

 

 
1

Return of capital from subsidiary from sales of accounts receivable
75

(a)

 

 

 
(75
)
 

Investment in unconsolidated affiliates, net

 

 

 
(13
)
 

 
(13
)
 
31

 

 
(10
)
 
(30
)
 
(50
)
 
(59
)
Cash flows (used in) provided by financing activities
 
 
 
 
 
 
 
 
 
 
 
Net short-term debt borrowings

 

 

 
9

 

 
9

Borrowings of long-term debt

 
1,108

 

 
19

 

 
1,127

Repayments of long-term debt
(544
)
 
(120
)
 

 
(376
)
 

 
(1,040
)
Net intercompany loan borrowings (repayments)
467

 
(882
)
 
(1
)
 
416

 

 

Long-term debt and credit facility financing fees
(12
)
 
(24
)
 

 

 

 
(36
)
Capital contribution from parent

 

 
10

 
15

 
(25
)
 

Common stock dividends paid

 
(83
)
 
(12
)
 

 
95

 

Return of capital to parent from sales of accounts receivable

 

 

 
(75
)
(a)
75

 

 
(89
)
 
(1
)
 
(3
)
 
8

 
145

 
60

Effect of exchange rates on cash and cash equivalents

 

 

 
(5
)
 

 
(5
)
Decrease in cash and cash equivalents
(51
)
 

 

 
(18
)
 

 
(69
)
Cash and cash equivalents (unrestricted) at beginning of period
276

 

 

 
125

 

 
401

Cash and cash equivalents (unrestricted) at end of period
$
225

 
$

 
$

 
$
107

 
$

 
$
332

MOMENTIVE SPECIALTY CHEMICALS INC.
SIX MONTHS ENDED JUNE 30, 2014
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Cash flows (used in) provided by operating activities
$
(267
)
 
$
(3
)
 
$
6

 
$
84

 
$
(6
)
 
$
(186
)
Cash flows provided by (used in) investing activities
 
 
 
 
 
 
 
 
 
 
 
Capital expenditures
(41
)
 

 

 
(37
)
 

 
(78
)
Acquisition of businesses
(52
)
 

 

 
(12
)
 

 
(64
)
Proceeds from sale of debt securities, net

 

 

 
3

 

 
3

Change in restricted cash

 

 

 
(2
)
 

 
(2
)
Disbursement of affiliated loan

 

 

 
(50
)
 

 
(50
)
Repayment of affiliated loan

 

 

 
50

 

 
50

Capital contribution to subsidiary
(16
)
 

 
(10
)
 

 
26

 

Investment in unconsolidated affiliates, net

 

 

 
(2
)
 

 
(2
)
Return of capital from subsidiary from sales of accounts receivable
186

(a)

 

 

 
(186
)
 

 
77

 

 
(10
)
 
(50
)
 
(160
)
 
(143
)
Cash flows provided by (used in) financing activities
 
 
 
 
 
 
 
 
 
 
 
Net short-term debt borrowings

 

 

 
27

 

 
27

Borrowings of long-term debt
115

 

 

 
45

 

 
160

Repayments of long-term debt
(69
)
 

 

 
(48
)
 

 
(117
)
Net intercompany loan borrowings (repayments)
9

 

 

 
(9
)
 

 

Capital contribution from parent

 

 
10

 
16

 
(26
)
 

Common stock dividends paid

 

 
(6
)
 

 
6

 

Return of capital to parent from sales of accounts receivable

 

 

 
(186
)
(a)
186

 

 
55

 

 
4

 
(155
)
 
166

 
70

Effect of exchange rates on cash and cash equivalents

 

 

 
(1
)
 

 
(1
)
Decrease in cash and cash equivalents
(135
)
 
(3
)
 

 
(122
)
 

 
(260
)
Cash and cash equivalents (unrestricted) at beginning of period
165

 
5

 

 
209

 

 
379

Cash and cash equivalents (unrestricted) at end of period
$
30

 
$
2

 
$

 
$
87

 
$

 
$
119

(a)
During the six months ended June 30, 2014, Momentive Specialty Chemicals Inc. contributed receivables of $186 to a non-guarantor subsidiary as capital contributions, resulting in a non-cash transaction. During the six months ended June 30, 2014, the non-guarantor subsidiary sold the contributed receivables to certain banks under various supplier financing agreements. The cash proceeds were returned to Momentive Specialty Chemicals Inc. by the non-guarantor subsidiary as a return of capital. The sale of receivables has been included within cash flows from operating activities on the Combined non-guarantor subsidiaries. The return of the cash proceeds from the sale of receivables has been included as a financing outflow and an investing inflow on the Combined Non-Guarantor Subsidiaries and Momentive Specialty Chemicals Inc., respectively.